0 Items - $0.00
Categories
A to Z

Alternative structural projections:

Sp-8-Br-cAMPS

8- Bromoadenosine- 3', 5'- cyclic monophosphorothioate, Sp- isomer ( Sp-8-Br-cAMPS ), sodium salt
Membrane-permeant and PDE-resistant PKA agonist
Cat. No.: B 002
    
CAS No.: [127634-20-2]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: B 002-05
Unit: 5 µmol / ~2.2 mg
$100.00
For other salt forms please inquire. Metabolically resistant activator of protein kinase A (cyclic AMP agonist). No metabolic side effects as observed with dibutyryl-cAMP or 8-Br-cAMP. Significantly more lipophilic and membrane-permeant compared to Sp-cAMPS (Cat. No. A 003). Detailed technical information and updated reference list available on request. References: Schaap et al., J. Biol. Chem., 268, 6323 - 6331 (1993); Sandnes et al., Pharmacol. Toxicol., 79, 15 - 22 (1996).
Cat. No. B 002
CAS number [127634-20-2]
Purity > 99% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₀H₁₀BrN₅O₅PS · Na
Molecular weight [g/mol] 446,2
cAMP modified at the exocyclic oxygen axial (Sp-)
Modifications 8-cAMP
Target PKA (cAK) Activator
Lipophilicity 1.66
Absorption max [nm] 264
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 17000
  • 1. Schwede F., Bertinetti D., Langerijs C. N., Hadders M. A., Wienk H., Ellenbroek J. H., de Koning E. J. P., Bos J. L., Herberg F. W., Genieser H.-G., Janssen R. A.Rehmann H., PLoS Biol., 13, 1 - 26 (2015), "Structure-Guided Design of Selective Epac1 and Epac2 Agonists"
  • 2. Ouyang M., Zhang L., Zhu J. J., Schwede F.Thomas S. A., PNAS, 105, 11993 - 11997 (2008), "Epac Signaling is Required for Hippocampus-dependent Memory Retrieval"
  • 3. Bryn T., Mahic M., Aandahl E. M., Froland S. S., Aukrust P.Tasken K., AIDS Res. Hum. Retroviruses, 24, 1013 - 1015 (2008), "Inhibition of Protein Kinase A Improves Effector Function of Monocytes from HIV-Infected Patients"
  • 4. Moll D., Prinz A., Gesellchen F., Drewianka S., Zimmermann B.Herberg F. W., J. Neural. Transm., 113, 1015 - 1032 (2006), "Biomolecular Interaction Analysis in Functional Proteomics"
  • 5. Kang G., Chepurny O. G., Malester B., Rindler M. J., Rehmann H., Bos J. L., Schwede F., Coetzee W. A.Holz G. G., J. Physiol.-London, 573, 595 - 609 (2006), "cAMP Sensor Epac as a Determinant of ATP-sensitive Potassium Channel Activity in Human Pancreatic Beta Cells and Rat INS-1 Cells"
  • 6. Santafé M. M., Lanuza M. A., Garcia N.Tomás J., Eur. J. Neurosci., 23, 2048 - 2056 (2006), "Muscarinic Autoreceptors Modulate Transmitter Release Through Protein Kinase C and Protein Kinase A in the Rat Motor Nerve Terminal"
  • 7. Li W. J., Wang T. K., Ma C., Xiong T., Zhu Y.Wang X., Amer. J. Physiol.-Cell Physiol., 291, 456 - 465 (2006), "Calcitonin Gene-related Peptide Inhibits Interleukin-1 Beta-induced Endogenous Monocyte Chemoattractant Protein-1 Secretion in Type II Alveolar Epithelial Cells"
  • 8. Haynes J. M.Cook A. L., Prostate, 66, 377 - 385 (2006), "Protein Kinase G-induced Activation of K-ATP Channels Reduces Contractility of Human Prostate Tissue"
  • 9. Bryn T., Mahic M., Enserink J. M., Schwede F., Aandahl E. M.Tasken K., J. Immunol., 176, 7361 - 7370 (2006), "The cyclic AMP-Epac1-Rap1 Pathway is Dissociated from Regulation of Effector Functions in Monocytes but Acquires Immunoregulatory Function in Mature Macrophages"
  • 10. Karege F., Schwald M.El Kouaissi R., Neuropsychopharmacol., 29, 805 - 812 (2005), "Drug-induced Decrease of Protein Kinase A Activity in BDNF Expression of Bipolar Affective Disorder"
  • 11. Godino M. D., Torres M.Sanchez-Prieto J., Neuropharm., 48, 547 - 557 (2005), "The Modulation of Ca2+ and K+ channels but not Changes in cAMP Signaling Contribute to the Inhibition of Glutamate Release by Cannabinoid Receptors in Cerebrocortical Nerve Terminals"
  • 12. Dalton G. D., Smith F. L., Smith P. A.Dewey W. L., Biochem. Pharmacol., 70, 152 - 160 (2005), "Chronic Delta(9)-Tetrahydrocannabinol Treatment Produces Antinociceptive Tolerance in Mice Without Altering Protein Kinase A Activity in Mouse Brain and Spinal Cord"
  • 13. Maron M. B., Folkesson H. G., Stader S. M.Walro J. M., Amer. J. Physiol.-Lung Cell M. Ph., 289, 349 - 354 (2005), "PKA Delivery to the Distal Lung Air Spaces Increases Alveolar Liquid Clearance After Isoproterenol-Induced Alveolar Epithelial PKA Desensitization"
  • 14. Miletic G., Hanson E. N., Savagian C. A.Miletic V., Neurosci. Lett., 360, 149 - 152 (2004), "Protein Kinase A Contributes to Sciatic Ligation-associated Early Activation of Cyclic AMP Response Element Binding Protein in the Rat Spinal Dorsal Horn"
  • 15. Mahic M., Bryn T., Enserink J. M., Schwede F., Aandahl E. M.Tasken K., Poster #THP019 Montreal, 12, 0 - 0 (2004), "Modulation of Monocyte Activation by Cyclic AMP is Mainly Mediated Through Protein Kinase A"
  • 16. Sheriff S., Chance W. T., Iqbal S., Rizvi T. A., Xiao C., Kasckow J. W.Balasubramaniam A., Peptides, 24, 245 - 254 (2003), "Hypothalamic Administration of cAMP Agonist/PKA Activator Inhibits Both Schedule Feeding and NPY-induced Feeding in Rats"
  • 17. Morgan E. E., Stader S. M., Hodnichak C. M., Mavrich K. E., Folkesson H. G.Maron M. B., Am. J. Physiol.-Lung. Cell. Mol. Physiol., 285, 578 - 583 (2003), "Postreceptor Defects in Alevolar Epithelial Beta-adrenergic Signaling after Prolonged Isoproterenol Infusion"
  • 18. Pacheco M. A., Pastoor T. E.Wecker L., Mol. Brain. Res., 114, 65 - 72 (2003), "Phosphorylation of the Alpha 4 Subunit of Human Alpha 4 Beta(2) Nicotinic Receptors: Role of cAMP-dependent Protein Kinase (PKA) and Protein Kinase C (PKC)"
  • 19. Nishiyama M., Hoshimo A., Tsai L., Henley J. R., Goshima Y., Tessier-Lavigne M., Poo M.-M.Hong K., Nature, 423, 990 - 995 (2003), "Cyclic AMP/GMP-dependent Modulation of Ca2+ Channels Sets the Polarity of Nerve Growth-cone Turning"
  • 20. Johansson C. C., Bryn T., Yndestad A., Eiken H. G., Bjerkeli V., Froeland S. S., Aukrust P.Taskén K., Abstract of the 13th Protein Kinase Symposium, 0, 2 - 2 (2002), "Cytokine Networks are Pre-activated in T Cells from HIV-infected Patients and under Control of cAMP as Assessed by Cytokine Arrays"
  • 21. Hung S. H., Madhusoodanan K. S., Boyd R. L., Baldwin J. L., Colman R. F.Colman R. W., Biochemistry, 41, 2962 - 2969 (2002), "A Nonhydrolyzable Reactive cAMP Analogue, (Sp)-8-[(4-bromo-2, 3-dioxobutyl)thio]adenosine 3', 5'-cyclic S-(methyl)monophosphorothioate, Irreversibly Inactivates Human Platelet cGMP-inhibited cAMP Phosphodiesterase at Micromolar Concentrations"
  • 22. Seebeck J., Tritschler S., Roloff T., Kruse M. L., Schmidt W. E.Ziegler A., Pflugers Arch., 443, 558 - 564 (2002), "The Outwardly Rectifying Chloride Channel in Rat Peritoneal Mast Cells is Regulated by Serine/Threonine Kinases and Phosphatases"
  • 23. Aandahl E. M., Moretto W. J., Haslett P. A., Vang T., Bryn T., Tasken K.Nixon D. F., J. Immunol., 169, 802 - 808 (2002), "Inhibition of Antigen-specific T Cell Proliferation and Cytokine Production by Protein Kinase A Type I"
  • 24. Matuszyk J., Cebrat M., Kalas W.Strzadala L., Int. Immunopharmacol., 2, 435 - 442 (2002), "HA1004, an Inhibitor of Serine/Threonine Protein Kinases, Restores the Sensitivity of Thymic Lymphomas to Ca2+-mediated Apoptosis through a Protein Kinase A-independent Mechanism"
  • 25. Spicuzza L., Belvisi M. G., Birrell M. A., Barnes P. J., Hele D. J.Giembycz M. A., Br. J. Pharmacol., 133, 1201 - 1212 (2001), "Evidence that the Anti-Spasmogenic Effect of the Beta-Adrenoceptor Agonist, Isoprenaline, on Guinea-Pig Trachealis is not Mediated by Cyclic AMP-dependent Protein Kinase"
  • 26. Choe E. S.McGinty J. F., J. Neurochem., 76, 401 - 412 (2001), "Cyclic AMP and Mitogen-Activated Protein Kinases are Required for Glutamate-Dependent Cyclic AMP Response Element Binding Protein and ELK-1 Phosphorylation in the Dorsal Striatum In Vivo"
  • 27. Adams A. C.Keefe K. A., J. Neurochem., 77, 326 - 335 (2001), "Examination of the Involvement of Protein Kinase A in D2 Dopamine Receptor Antagonist-induced Immediate Early Gene Expression"
  • 28. Fleischhauer J. C., Mitchell C. H., Peterson-Yantorno K., Coca-Prados M.Civan M. M., Am. J. Physiol.-Cell Physiol., 281, 1614 - 1623 (2001), "PGE2, Ca2+, and cAMP Mediate ATP Activation of Cl- Channels in Pigmented Ciliary Epithelial Cells"
  • 29. Adams A. C.Keefe K. A., J. Neurochem., 77, 326 - 335 (2001), "Examination of the Involvement of Protein-Kinase A in D2 Dopamine Receptor Antagonist-Induced Immediate Early Gene Expression"
  • 30. Tasken K., Moutschen M., Rahmouni-Piette S., Aandahl E. M., Aukrust P., Froeland S. S., Johansson C. C., Hannson V.Klaveness J., Patent No. 2002007721, 0, 0 - 0 (2001), "Method Using a Cyclooxygenase 2 (Cox-2 Inhibitor for Treatment of an Immunodeficiency Condition"
  • 31. Tzavara E. T., Valjent E., Firmo C., Mas M., Beslot F., Defer N., Roques B. P., Hanoune J.Maldonado R., Eur. J. Neurosci., 12, 1038 - 1046 (2000), "Cannabinoid Withdrawal is Dependent upon PKA Activation in the Cerebellum"
  • 32. Johansson C., Aandahl E. M., Aukrust P., Müller F., Hansson V., Froeland S. S.Tasken K., 12th Protein Kinase Symp. NO/cGMP and Protein Kinase Signaling Bad Brückenau/Germany, 0, 0 - 0 (2000), "Protein Kinase A Type I Antagonist as an Immune-Modulating Therapy"
  • 33. Suzuki Y., Saitoh M., Suzumori K., Kajikuri J.Itoh T., Br. J. Pharmacol., 131, 37 - 42 (2000), "Characterization of Changes in Mechanical Responses to Histamine in Omental Resistance Arteries in Pre-Eclampsia"
  • 34. Haynes J. M., Br. J. Pharmacol., 130, 685 - 691 (2000), "A(2A) Adenosine Receptor Mediated Potassium Channel Activation in Rat Epididymal Smooth Muscle"
  • 35. Li J., Yang S.Billiar T. R., J. Biol. Chem., 275, 13026 - 13034 (2000), "Cyclic Nucleotides Suppress Tumor Necrosis Factor Alpha-Mediated Apoptosis by Inhibiting Caspase Activation and Cytochrome c Release in Primary Hepatocytes via a Mechanism Independent of Akt Activation"
  • 36. Koch A., Nasuhara Y., Barnes P. J., Lindsay M. A.Giembycz M. A., Br. J. Pharmacol., 131, 981 - 989 (2000), "Extracellular Signal-Regulated Kinase 1/2 Control Ca2+-Independent Force Development in Histamine-Stimulated Bovine Tracheal Smooth Muscle"
  • 37. Choe E. S.McGinty J. F., Neuroscience, 101, 607 - 617 (2000), "N-Methyl-D-Aspartate Receptors and P38 Mitogen-Activated Protein Kinase are Required for cAMP-Dependent Cyclase Response Element Binding Protein and ELK-1 Phosphorylation in the Striatum"
  • 38. Takeuchi T., Kishi M., Hirayama N., Yamaji M., Ishii T., Nishio H., Hata F.Takewaki T., J. Physiol., 514, 177 - 188 (1999), "Tyrosine Kinase Involvement in Apamin-sensitive Inhibitory Responses of Rat Distal Colon"
  • 39. Aukrust P., Aandahl E. M., Skalhegg B. S., Nordoy I., Hansson V., Tasken K., Froland S. S.Müller F., J. Immunol., 162, 1178 - 1185 (1999), "Increased Activation of Protein Kinase A Type I Contributes to the T Cell Deficiency in Common Variable Immunodeficiency"
  • 40. Myklebust J. H., Josefsen D., Blomhoff H. K., Levy F. O., Naderi S., Reed L. C.Smeland E. B., J. Cell. Physiol., 180, 71 - 80 (1999), "Activation of the cAMP Signaling Pathway Increases Apoptosis in Human Beta-Precursor Cells and is Associated with Downregulation of Mcl-1 Expression"
  • 41. Boulanger L.Poo M.-M., Science, 284, 1982 - 1984 (1999), "Gating of BDNF-Induced Synaptic Potentiation by cAMP"
  • 42. Pfeifer A., Ruth P., Dostmann W., Sausbier M., Klatt P.Hofmann F., in Rev. Physiol. Biochem. Pharmacol. Berlin / Springer, 135, 105 - 149 (1999), "Structure and Function of cGMP-Dependent Protein Kinases"
  • 43. Song H., Poo M.-M., Ming G.-L., Tessier-Lavigne M.He Z., Patent No. WO 2000012099, 0, 0 - 0 (1999), "Cyclic Nucleotide-dependent Protein Kinase Activators for Promoters of Neural Regeneration"
  • 44. Cho-Chung Y. S., Jastorff B.Genieser H.-G., USA patent 5916, 843, 0 - 0 (1998), "Cyclic AMP Analogues, Individually and in Pairs, to Inhibit Neoplastic Cell Growth"
  • 45. Aandahl E. M., Aukrust P., Skalhegg B. S., Müller F., Froland S. S., Hansson V.Tasken K., FASEB J., 12, 855 - 862 (1998), "Protein Kinase A Type I Antagonists Restores Immune Responses of T Cells from HIV-infected Patients"
  • 46. Keryer G., Alsat E., Tasken K.Evain-Brion D., J. Cell Sci., 111, 995 - 1004 (1998), "Cyclic AMP-dependent Protein Kinases and Human Trophoblast Cell Differentiation in Vitro"
  • 47. Tasken K., Aandahl E. M., Aukrust P., Müller F., Froland S. S.Hansson V., Intl. Patent Appl. PCT, 0, 0 - 0 (1998), "Use of Immunomodulating Agents"
  • 48. Beaumont V., Hepworth M. B., Luty J. S., Kelly E.Henderson G., J. Biol. Chem., 273, 33174 - 33183 (1998), "Somatostatin Receptor Desensitization in NG108-15 Cells"
  • 49. Bowen D.Johe K. K., US Patent No. 6284539, 0, 0 - 0 (1998), "Induction of Development of Dopaminergic Cells from Neural Precursors by Increasing Level of Expression of the Nurr1 Gene"
  • 50. Torgersen K. M., Vaage J. T., Levy F. O., Hansson V., Rolstad B.Tasken K., J. Biol. Chem., 272, 5495 - 5500 (1997), "Selective Activation of cAMP-Dependent Protein Kinase Type I Inhibits Rat Natural Killer Cell Cytotoxicity"
  • 51. Armstead W. M., Brain Res., 768, 177 - 84 (1997), "Role of Impaired cAMP and Calcium-Sensitive K+ Channel Function in Altered Cerebral Hemodynamics Following Brain Injury"
  • 52. Wilderman M. J.Armstead W. M., Eur. J. Pharmacol., 309, 243 - 249 (1996), "Influence of cAMP on Cerebrospinal Fluid Opioid Concentration: Role in cAMP-Induced Pial Artery Dilation"
  • 53. Holen I., Gordon P. B., Stroemhaug P. E.Seglen P. O., Eur. J. Biochem., 236, 163 - 170 (1996), "Role of cAMP in the Regulation of Hepatocytic Autophagy"
  • 54. Sandnes D., Jacobson F. W., Refsnes M.Christoffersen T., Pharmacol. Toxicol., 79, 15 - 22 (1996), "8-Bromo-cAMP and 8-CPT-cAMP Increase the Density of ß-Adrenoceptors in Hepatocytes by a Mechanism Not Mimicking the Effect of cAMP"
  • 55. Stella N.Magistretti P. J., J. Biol. Chem., 271, 23705 - 23710 (1996), "Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Potentiate the Glutamate-evoked Release of Arachidonic Acid from Mouse Cortical Neurons- Evidence for a cAMP-independent Mechanism"
  • 56. Hatton C. J.Peers C., Pflugers Arch.- Eur. J. Physiol., 433, 129 - 135 (1996), "Hypoxic Inhibition of K+ Currents in Isolated Rat Type I Carotid Body Cells - Evidence Against the Involvement of Cyclic Nucleotides"
  • 57. Levin G., Peretz T., Chikvashvili D., Jing J.Lotan I., J. Mol. Neurosci., 7, 269 - 276 (1996), "Deletion of the N-Terminus of a K+Channel Brings About Short-Term Modulation By cAMP and Beta-1-Adrenergic Receptor Activation"
  • 58. Ruchaud S., Zorn M., Davilar-Villar E., Genieser H.-G., Hoffmann C., Gjertsen B. T., Doeskeland S. O., Jastorff B.Lanotte M., Cell. Pharmacol., 2, 127 - 140 (1995), "Evidence for Several Pathways of Biological Response to Hydrolysable cAMP-Analogues Using a Model System of Apoptosis in IPC-81 Leukaemia Cells"
  • 59. Levin G., Keren T., Peretz T., Chikvashvili D., Thornhill W. B.Lotan I., J. Biol. Chem., 270, 14611 - 14618 (1995), "Regulation of RCK1 Currents With a cAMP Analog Via Enhanced Protein Synthesis and Direct Channel Phosphorylation"
  • 60. Genieser H.-G., Proc. 9. Int. Conf. Second Mess. & Phosphoprot. TN USA, 0, 0 - 0 (1995), "Lipophilic Ranking of Biologically Important Cyclic Nucleotides"
  • 61. Petritsch C., Woscholski R., Edelmann H. M. L.Ballou L. M., J. Biol. Chem., 270, 26619 - 26625 (1995), "Activation of p70 S6 Kinase and erk-encoded Mitogen-activated Protein Kinases is Resistant to High Cyclic Nucleotide Levels in Swiss 3T3 Fibroblasts"
  • 62. Schäfer C., Steffen H., Printz H.Göke B., Can. J. Physiol. Pharmacol., 72, 1138 - 1147 (1994), "Effects of Synthetic Cyclic AMP Analogs on Amylase Exocytosis from Rat Pancreatic Acini"
  • 63. Schaap P., Van Ments-Cohen M., Soede R. D. M., Brandt R., Firtel R. A., Dostmann W., Genieser H.-G., Jastorff B.Van Haastert P. J. M., J. Biol. Chem., 268, 6323 - 6331 (1993), "Cell-permeable Non-hydrolyzable cAMP Derivatives as Tools for Analysis of Signaling Pathways Controlling Gene Regulation in Dictyostelium"
  • 64. Jastorff B., Genieser H.-G.Cho-Chung Y. S., Patent WO9321929 of November 11, 0, 0 - 0 (1993), "Phosphorothioate Derivatives of Cyclic AMP Analogues"
  • 65. Schäfer C., Printz H.Göke B., Proc. EPC Meeting FRG October, 0, 0 - 0 (1992), "Effect of Sp - and Rp - Diasteromers of Adenosine Cyclic 3', 5' - phosphorothioate on Rat Pancreatic Acini"
  • 66. Jastorff B., Proceeding of the 8th. Internatl. Conference on Second Messengers & Phosphoproteins UK, 0, 0 - 0 (1992), "A New Generation of Cyclic Nucleotide Analogues : Site Specific, Enzyme Selective, Agonistic or Antagonistic and Resistant to Hydrolysis"
  • 67. Yokozaki H., Tortora G., Pepe S., Maronde E., Genieser H.-G., Jastorff B.Cho- Chung Y. S., Cancer Res., 52, 2504 - 2508 (1992), "Unhydrolysable Analogs of Cyclic Adenosine- 3', 5' - Monophosphate Demonstrating Growth Inhibition and Differentiation in Human Cancer Cells"
  • 68. Jastorff B., Maronde E., van Bemmelen M. X. P., Zorn M.Störmann R., Proc. 3rd Intl. Symp. Mol. Aspects Chemother. Poland, PWN Warsaw & Springer Verlag New York, 0, 57 - 87 (1991), "Cyclic Nucleotide Metabolism as a Target in Chemotherapy"
  • 69. Kessin R. H., Fleischmann R. D., Gottesmann M. M., Jastorff B.Van Lookeren Campagne M. M., in Adv. in Second. Mess. Phosphoprot. Res. / eds. S.J. Strada H. Hidaka ) Raven Press New York, 25, 0 - 0 (1991), "Use of the Yeast Low Km cAMP Phosphodiesterase Gene to Control Cyclic AMP Levels in Mammalian Cells"
  • 70. Van Lookeren Campagne M. M., Diaz F. V., Jastorff B., Winkler E., Genieser H.-G.Kessin R. W., J. Biol. Chem., 265, 5847 - 5854 (1990), "Characterization of the Yeast Low Km cAMP- Phosphodiesterase With cAMP Analogues"
  • 71. Van Ments-Cohen M., Dissertation University of Leiden ( The Netherlands ), 108, 0 - 0 (1990), "cAMP Receptors and Signal Transduction in Dictyostelium Discoideum. A Comparative Study With cAMP Derivatives"
  • 72. Dostmann W. R. G., Taylor S. S., Genieser H.-G., Jastorff B., Doeskeland S. O.Oegreid D., J. Biol. Chem., 265, 10484 - 10491 (1990), "Probing the Cyclic Nucleotide Binding Sites of cAMP-Dependent Protein Kinase I and II with Analogs of Adenosine- 3', 5'- Cyclic Phosphorothioates"
  • 73. Braumann T.Jastorff B., J. Chromatography, 329, 321 - 330 (1985), "Physico-chemical Characterization of Cyclic Nucleotides by Reversed-Phase High-Performance Liquid Chromatography. I. Cation Binding in the Mobile Phase"

Show more